Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 22Leukemia, Myeloid, Acute 20Breast Neoplasms 19Neoplasm Metastasis 16Pancreatic Neoplasms 15Multiple Myeloma 13Melanoma 12Prostatic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Lymphoma 10Colorectal Neoplasms 10Carcinoma, Renal Cell 10Burkitt Lymphoma 10Triple Negative Breast Neoplasms 9Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Mouth Neoplasms 8Glioma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Oropharyngeal Neoplasms 7Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Laryngeal Neoplasms 7Fallopian Tube Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma 7Nasopharyngeal Carcinoma 6Endometrial Neoplasms 6Wilms Tumor 5

Interventions

sofosbuvir-velpatasvir drug combination 1atezolizumab 1Specimen Handling 1Simvastatin 1Magnetic Resonance Spectroscopy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Specimen Handling × 30 days × Clear all
NCT02968810 2026-05-29

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting
52 enrolled 15 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡